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The activity of Nitric Oxide Synthase 2 (NOS2) was found in oral squamous cell carcinomas (OSCC) but not in 
normal mucosa. Molecular changes associated to early carcinogenesis have been found in mucosa near carcino-
mas, which is considered a model to study field cancerization. The aim of the present study is to analyze NOS2 
expression at the histologically normal margins of OSCC. 
Study Design: Eleven biopsy specimens of OSCC containing histologically normal margins (HNM) were ana-
lyzed. Ten biopsies of normal oral mucosa were used as controls. The activity of NOS2 was determined by im-
munohistochemistry. Salivary nitrate and nitrite as well as tobacco and alcohol consumption were also analyzed. 
The Chi-squared test was applied.
Results:  Six out of the eleven HNM from carcinoma samples showed positive NOS2 activity whereas all the control 
group samples yielded negative (p=0.005). No statistically significant association between enzyme expression and 
tobacco and/or alcohol consumption and salivary nitrate and nitrite was found.
Conclusions: NOS2 expression would be an additional evidence of alterations that may occur in a state of field 
cancerization before the appearance of potentially malignant morphological changes.
Key words: Field cancerization, oral squamous cell carcinoma, Nitric Oxide Synthase 2 (NOS2), malignity 
markers. 
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Introduction 
Despite the fact that the oral cavity is an accessible 
location for medical examination, most cases of oral 
cancer (OC) are detected at advanced stages, which 
is the reason for the low survival rates recorded. OC 
has high morbidity rates, with an overall survival rate 
of 34-56% (1,2). In Cordoba, Argentina, mortality 
rates have increased noticeably in females, 77% for 
the period 1975-2000 (3). These tendencies probably 
indicate a change in women s´ habits, such as increase 
in smoking and alcohol drinking (4-6). In a previous 
study, we found that late diagnosis is mainly due to 
professional delay in indicating a biopsy (7). Loco-
regional recurrence is the main reason for the failure of 
head and neck cancer treatments. Failure is associated to 
the remaining cancer cells in the surgical margins that 
are considered negative in the pathologically examined 
sample (8). This could be explained a lack of sensitivity 
of the method used to identify cells that have already 
started their malignity transformation and have not yet 
developed a pathological phenotype. Besides Slaughter 
et al. introduced the concept of “field cancerization” to 
explain the increased risk of malignant transformation 
in large areas of the epithelial lining of the upper 
aerodigestive tract, modified by tobacco and alcohol 
consumption (9). This hypothesis was based on the high 
incidence of second primary tumors or multifocal cancer 
and was proved by the demonstration of molecular 
changes in clinically healthy mucosa of smoking patients 
(10,11). Furthermore, the sequential or simultaneous 
development of oral premalignant and/or malignant 
lesions in a single patient evidences progressive 
genotypic and phenotypic alterations associated to 
field cancerization (12). The search for markers of field 
cancerization before the appearance of premalignant 
morphological alterations is of biological interest and 
clinically relevant in terms of early diagnosis and OC 
prevention. We have tried to detect a field cancerization 
by means of immunohistochemical (IHC) reactions, 
easy to apply to routine biopsic material (13-16).
Nitric oxide (NO) is a small, relatively stable, free radi-
cal gas, found both in normal and in malignant tissues 
(17,18). It is synthesized by nitric oxide synthases (NOS) 
which exists in three different isoforms: neuronal NOS 
(NOS1), endothelial NOS (NOS3), and inducible NOS 
(NOS2). Lipopolysaccharide, interferon and numerous 
other factors induce NOS2 expression in endothelial 
and inflammatory cells (19,20).  NOS2 is also expressed 
in some normal epithelia such as airway epithelium, ba-
sal keratinocyte layer of normal skin, and normal sali-
vary ducts (21). Neither NOS2 protein nor mRNA was 
found in normal oral mucosa (22). Neoplastic tissues, 
including head and neck carcinomas, over-express the 
enzyme. NOS2 has been involved in tumor growth, mu-
tagenicity, angiogenesis and metastasis (23,24). NOS2 
activity was also found in oral epithelial dysplasia, sub-
mucous fibrosis and verrucous hyperplasia (25).
Considering that alterations associated to field 
cancerization have been found in normal epithelia near 
oral carcinomas (11-14,16), the present study focuses on 
the evaluation of the NOS2 expression in these areas as 
another biomarker for risk of malignant transformation. 
Since NOS2 enzyme intervenes in NO synthesis and 
given the fact that NO is highly reactive, saliva levels 
were determined by measuring nitrate and nitrite, which 
are the NO oxidation products (26,27).
Material and Methods
Tissue sources:
Out of eleven biopsy and/or excised surgical archive 
specimens of oral squamous cell carcinomas (OSCC), 
only samples involving histologically normal oral 
mucosa were selected, provided they were situated at 
more than 5mm away from the tumor without or with 
very mild inflammatory infiltrate.
Ten specimens of clinically and histologically normal 
oral mucosa obtained during surgery for deep seated 
benignant lesions were selected as control group (CG). 
All the samples belonged to patients attending the Oral 
Pathology Department, Facultad Odontología, Univer-
sidad Nacional de Córdoba. All the cases included pre-
sented complete clinical records and saliva complemen-
tary studies, as well.
Exclusion criteria were pregnancy, use of vitamin 
supplements, antibiotics or anti-inflammatory agents, 
and previous oncological treatment. 
Due to the well known influence of tobacco and alco-
hol in the development of a sub-clinic level of field can-
cerization, patients with a history of more than 200000 
cigarettes or with more than 50g of alcohol per day were 
discarded (28). 
A complete clinical record included the following data: 
Clinical stage of patients: According to the Union for 
International Cancer Control (UICC) criteria, stages III 
and IV were defined as advanced tumors and stages I 
and II as early ones (29). 
Tobacco consumption: The total number of cigarettes 
smoked during the patient’s lifetime was estimated 
according to Zanetti et al. method (30), multiplying the 
number of cigarettes smoked per year by the number of 
years. Patients were categorized as: non-smokers (never 
having smoked), or smokers (having smoked more than 
100,000 cigarettes). 
Alcohol consumption: one alcoholic unit per day (1U = 
8 to 10 g of ethanol = 1 glass of wine = 1/4 liter of beer 
= 1 measure of spirits) was considered alcohol exposure 
according to Pentenero et al. 2008 (31). The total 
alcohol intake was estimated considering the grams 
per day thus obtaining the approximate lifetime alcohol 
consumption. Patients were categorized according to 
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their consumption as: non-drinkers (never having drunk) 
and drinkers (having consumed more than 100,000 g). 
Concentration of nitrate and nitrite in saliva samples: 
Samples were obtained and processed following 
laboratory standardized conditions.
Nitrite levels were considered low or high according to 
whether concentrations were lower or higher than 100 
µM respectively, while nitrate levels were considered 
low or high according to whether concentrations were 
lower or higher than 800 µM, respectively.
Immunohistochemistry: Sections of 7µm thick were 
obtained; endogenous peroxidase was blocked by 
immersion in 0.5% methanolic peroxide for 15 min. 
Antigen retrieval was performed with Citra (Biogenex) 
in 3 cycles of 4 minutes each, at 400W microwaves. The 
sections were then incubated overnight with the primary 
antibody (anti-NOS2, C-terminal, rabbit, Cat. sc-651, 
Santa Cruz Biotechnology, Inc.), diluted 1:50 in PBS in 
a humid chamber at 4ºC. Antibody binding sites were 
visualized using a streptavidin-peroxidase detection 
kit (Kit Multilink, Biogenex). Slides with and without 
hematoxylin counterstain were mounted. As positive 
control a section of a single block of apical granuloma 
was included in each staining batch, rendering highly 
positive for NOS2. As negative control for antibody 
specificity tissue samples were included in which the 
primary antibody was omitted.
The presence of brown precipitate in the cytoplasm 
was considered positive provided it could be clearly 
distinguished from the negative reaction of the nucleus 
in preparations without counterstaining.
In each case the staining intensity was evaluated by 
comparing it with the respective positive control of the 
same staining batch. A reaction evident but less intense 
than the control, was considered mildly positive; while a 
reaction similar or higher than the control, was considered 
positive or highly positive respectively. In the present 
study the tumor epithelial cords and their histologically 
normal margins were grouped in positive (+) or negative 
(-), independently from the intensity of the reaction. Two 
oral pathologists, who ignored the clinical data, evaluated 
the immuno-histochemical assays.
Statistical analysis: A Chi Square test was applied to 
evaluate the differences in NOS2 expression, between 
the histologically normal margins of OSCC and the con-
trol group, and between tobacco and alcohol consump-
tion and salivary nitrate and nitrite concentrations. 
Results 
Sample features: 
In this cross-sectional study 21 samples were examined: 
11 OSCC samples corresponding to the study group 
and 10 samples as control group. No statistically 
significant association was found regarding tobacco and 
alcohol consumption in both groups. Table 1 shows the 
characteristics of the included cases. 
NOS2 citoplasmatic expression in OSCC
NOS2 activity is expressed in the cellular cytoplasm 
Characteristics Study Group (%) 
Control
Group (%) p*
Samples(n) 11 (52) 10 (48) - 
Sex    
female 4 (36) 8 (80) - 
male 7 (64) 2 (20) - 
Age    
mean 63     52      - 
range 51-77 34-82 - 
Tobacco consumption(n)    
yes 9 (82) 5 (50) 0,12 
no 2 (18) 5 (50)  
Alcohol consumption(n)    
yes 9 (82) 6 (60) 0,27 
no 2 (18) 4 (40)  
Nitrite (uM)    
high 6 (55) 5 (50) 0,84 
low 5 (45) 5 (50)  
Nitrate (uM)    
high 3 (27) 6 (60) 0,13 
low 8 (73) 4 (40)  
NOS2**    
positive 6 (54) - 0,005 
negative 5 (46) 10 (100)  
Table 1.  Characteristics of the study and control group.
• Chi square test.
** Histologically normal margins of oral squamous cell carcinoma. 
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as a diffuse precipitate without any nucleous reaction. 
Carcinoma reactivity does not differ from the existing 
one in the literature (32). A different intensity reaction 
was observed in the OSCC epithelial cords, in the stroma 
inflammatory infiltrate and in the vascular endothelium 
(Fig. 1).
Histologically normal mucosa of the tumor margins 
showed reactions ranging from negative to positive 
expressions in all epithelial layers (Fig. 2). Six out of 
the 11 cases under study were positive while in the CG 
the epithelium was negative for NOS2 reaction in all 
Fig. 1. Immunohistochemical expression of NOS2 in epithelial cords 
of OSCC. Haematoxilin counterstain (x25). 
cases (p= 0.005). The Odds Ratio (OR) could not be 
calculated since the control group did not express NOS2 
in any sample; therefore, the corresponding frequency 
was zero (0).
Only a moderate NOS2 expression in the connective 
tissue was found in both groups whenever isolated 
inflammatory cells were present.
Tables 2 and 3 show the characteristics of the NOS2 
expression in study and those of the control group, 
respectively.
Nitrite and nitrate levels
The salivary nitrate and nitrite levels were similar both 
in carcinoma and control groups (see Table 1).
Discussion
Tumor epithelial cords were positive for NOS2; the 
degrees of expression were variable, in agreement 
with previous studies (32). Activation of NOS2 has 
also been demonstrated in lung, colon and prostate 
cancer and in melanoma (25,33-36) and has been 
related to cervical lymph node metastasis and to greater 
metastatic potential (25,32). Over-expression of NOS2 
Fig. 2. NOS2 expression in histologically normal margins of OSCC. 
Endothelial and inflammatory cells were also positive (x10).
Sample NOS2tumor
NOS2
(NTEB)* Location Stage 
1 (+) (-) oropharynx advanced** 
2 (+) (+) alveolar ridge early 
3 (+) (+) alveolar ridge early 
4 (+) (-) tongue early 
5 (-) (-) lengua early 
6 (+) (+) floor of mouth advanced** 
7 (+) (+) cheek early 
8 (-) (+) alveolar ridge early 
9 (-) (+) tongue advanced** 
10 (+) (-) gum advanced** 
11 (-) (-) floor of mouth advanced** 
Table 2. Study Group (OSCC): NOS2 expression, tumor stage 
and location. 
 * histologically normal margins of oral squamous cell carci-
noma. 
** All the patients diagnosed at advanced stage had nodes (N).
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has been found in dysplasia specimens (17,33,37) and 
has also been involved in early cellular changes leading 
to malignity such as transformation of normal cells or 
growth of altered cells (36).
The present study not only analyzed NOS2 expression 
in tumor tissues but also demonstrated its activity in the 
surrounding normal tumor epithelium. This is the first 
time in which a NOS2 remarkable expression is reported 
for the histologically normal mucosa surrounding 
carcinomas. In these still morphologically unaltered 
areas, genetic and histochemical alterations typical of a 
field cancerization have been proven (9,10).
Since NOS2 expression is triggered by inflammatory 
reactions, and with the aim of determining if its 
expression in OSCC normal margins is independent 
from the inflammatory response, we only included 
samples bearing the inevitable presence of some 
isolated inflammatory cells in both study and control 
groups. The strict inclusion criteria limited the number 
of samples available. 
It is well known that the sum of genetic alterations 
lead to gradual phenotypic changes. In this work, some 
positively stained tumors turned out to have negative 
margins. Conversely, some negative tumors were found 
to have positive margins. The complexity and the 
heterogeneity of the NOS2 expression in tumors and 
within a same tumor has been found in the literature (36); 
the same finding was reported when other cancerization 
markers have been used (12,15). It has been suggested 
that NOS2, which is over expressed in transformed 
cells, can mediate endothelial proliferation through NO 
which, in turn, acts as a cellular signal for angiogenesis 
(25). We found an increased NOS2 expression in the 
OSCC endotelial cells. Interestingly, we had previously 
demonstrated a rise in sub-epithelial capillaries of 
dysplastic leukoplakia, non-invasive margins of 
carcinoma (15) and oral mucosa of alcoholic patients 
(16). Moreover, NO has been suggested to modulate 
different cancer-related events including angiogenesis, 
apoptosis, cell cycle, invasion and metastasis (20). The 
anti-tumoral NO effects described in other research 
works stimulates apoptosis and inhibit angiogenesis 
(17,18,38), although further clinical studies of cancer 
patients are still necessary. The biological activity of 
NO depends on variables such as the originating source, 
its local concentration, tumor microenvironment and 
spatial and temporal constants that may determine the 
ON function. 
More studies are necessary to establish the role of the 
path ON/NOS2 in tumor genesis and evolution and to 
determine the usefulness of NOS2 inhibitors as chemo-
prevention medication (39,40).
The levels of salivary nitrite and nitrate were measured 
looking for their relationship with the expression of 
NOS2 in patients with tumors. No differences were 
found with the control group. Taking into account the 
fact that nitrite concentration in saliva is associated 
with age, diet composition, fungal or bacterial infection 
and with tobacco and alcohol consumption, we find 
it important to continue enlarging our sample in the 
search for a possible association. 
NOS2 expression in clinically and histologically normal 
mucosa would be an additional evidence of the alterations 
that may occur in a field of cancerization before potentially 
malignant morphological changes appear.
This preliminary data suggest that the expression 
of NOS2 could be useful for the diagnosis of “field 
cancerization” or “at risk mucosa” in those patients 
exposed to risk factors like excessive tobacco and 
alcohol consumption but who have not yet evinced 
lesions in the oral mucosa.
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